Infrastructure Capital Advisors, LLC Abb Vie Inc. Transaction History

Infrastructure Capital Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $374,266 - $448,844	-2,706 Reduced 61.68%	1,681 $271,000
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $328,277 - $376,512	2,446 Added 126.02%	4,387 $589,000
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $267,120 - $339,597	1,941 New	1,941 $297,000
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $333,140 - $421,518	-3,101 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $329,946 - $374,538	3,101 New	3,101 $337,000
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $315,840 - $351,864	-3,002 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $307,104 - $338,085	3,002 New	3,002 $325,000
Q4 2020 Feb 12, 2021	SELL	$80.49 - $108.67 $160,980 - $217,340	-2,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $171,820 - $201,660	2,000 New	2,000 $175,000

4,095

1.28B

16.7M

15M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $357B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Infrastructure Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Infrastructure Capital Advisors, LLC with notifications on news.